This session provides a focused overview of the relationship between neurodiversity and substance use disorders, including core concepts in autism spectrum disorder and ADHD and their impact on addiction risk, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.
What This Covers • Core concepts in neurodiversity, including autism spectrum disorder and ADHD • The relationship between neurodivergent conditions and risk for substance use disorders • Shared neurobiologic mechanisms and co-occurring psychiatric conditions • Clinical presentations of substance use disorders in neurodivergent individuals • Patterns of substance use influenced by factors such as social anxiety, sensory processing, and adaptive coping strategies • Adapted approaches to screening, treatment planning, and care delivery • Strategies to improve engagement and outcomes through individualized, patient-centered care
How This Resource Is Used This session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.
Eleasa Sokolski, MD
Dr. Sokolski is an addiction medicine physician specializing in the treatment of substance use and co‑occurring psychiatric disorders. She is board certified in Internal Medicine and Psychiatry.
Her work focuses on integrated care, medical education, and the application of psychotherapy in clinical settings, with an emphasis on patient‑centered approaches to recovery.
To support a meaningful learning experience and recognize your participation:
Access PeriodAccess to this recording is available through June 30, 2027, in alignment with ACAAM’s annual academic cycle.
Recording Release CycleACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.